Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Incyte Achieves $50 Million Milestone as Oral JAK1/JAK2 Inhibitor Baricitinib Advances into Phase III Development for Rheumatoid Arthritis
Yahoo
Thu, 11/15/12 - 11:06 am
Tags:
baricitinib, Incyte, JAK inhibitors, Eli Lilly, rheumatoid arthritis
3 Potential Partners for Amarin
Motley Fool
Thu, 11/15/12 - 10:43 am
Tags:
M&A, Amarin, AstraZeneca, Merck, Eli Lilly
Lilly arthritis drug shows durability in study
Reuters
Tue, 11/13/12 - 05:36 pm
Tags:
Eli Lilly, baricitinib, Incyte, rheumatoid arthritis
Will This Big Pharma Continue to Trade Up?
Motley Fool
Sat, 11/10/12 - 08:32 am
Tags:
Eli Lilly
Eli Lilly And Company: Today's Featured Drugs Laggard
The Street
Sat, 11/3/12 - 11:33 am
Tags:
Eli Lilly
Lilly to Expand Indianapolis Insulin Manufacturing
Pharma Pro
Fri, 11/2/12 - 10:15 am
Tags:
Eli Lilly, drug manufacturing, diabetes, insulin
Eli Lilly: Cymbalta Patent Cliff
Seeking Alpha
Thu, 11/1/12 - 10:57 am
Tags:
patent cliff, Eli Lilly, Cymbalta
European Commission approves Eli Lilly's Cialis to treat enlarged prostate symptoms
Yahoo/AP
Tue, 10/30/12 - 11:36 am
Tags:
Europe, enlarged prostate, Cialis, Eli Lilly
Merck: Current Investors Should Hold This Pharma Long-Term
Seeking Alpha
Tue, 10/30/12 - 11:33 am
Tags:
Merck, Eli Lilly, Pfizer
Bristol-Myers Squibb and Eli Lilly: The Patent Cliff Strikes Back
Wall Street Cheat Street
Sat, 10/27/12 - 12:19 pm
Tags:
Bristol-Myers Squibb, Eli Lilly
Pharmaceutical Stocks Are All-of-a-Sudden Hot Again: Read About Drugs and Dividends
Forbes
Sat, 10/27/12 - 11:40 am
Tags:
Merck, Eli Lilly, Abbott Laboratories, Novartis, Pfizer
Eli Lilly And Company (LLY): Today's Featured Drugs Laggard
The Street
Sat, 10/27/12 - 11:36 am
Tags:
Eli Lilly
European approval granted for Trajenta tablets as add-on therapy in Diabetes
Yahoo/Fly on the Wall
Fri, 10/26/12 - 11:12 am
Tags:
Europe, Trajents, diabetes, Eli Lilly, Boehringer Ingelheim
Eli Lilly's 3rd quarter profit climbs 7 pct, revenue slides and drugmaker backs 2012 forecast
Yahoo/AP
Wed, 10/24/12 - 10:57 am
Tags:
Eli Lilly, earnings
Could Tofacitinib Save Pfizer?
Seeking Alpha
Tue, 10/23/12 - 04:20 pm
Tags:
tofacitinib, Pfizer, JNJ, Eli Lilly, rheumatoid arthritis
3 Diabetes Phase 3 Wins
Motley Fool
Tue, 10/23/12 - 04:19 pm
Tags:
Merck, Sanofi, Eli Lilly, diabetes, AstraZeneca, Bristol-Myers Squibb, dulaglutide, Amylin
Eli Lilly's Upcoming Earnings: What You Need To Know
Motley Fool
Mon, 10/22/12 - 11:37 am
Tags:
earnings, Eli Lilly
Lilly Diabetes Medicine Meets Goal in Three Studies
Bloomberg
Mon, 10/22/12 - 11:23 am
Tags:
diabetes, Eli Lilly, dulaglutide
5 Things to Watch This Week in the Health-Care Sector
Motley Fool
Mon, 10/22/12 - 10:52 am
Tags:
Regeneron, Eyela, Gilead, GS-7977, Merck, Eli Lilly, Singulair, Molina Healthcare
Is Eli Lilly Narrowing in on the Billion Dollar Prize?
Wall Street Cheat Street
Sat, 10/20/12 - 10:40 am
Tags:
Eli Lilly, Alzheimer's disease, solanezumab

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.